1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
  2. "Melanoma and Immunotherapeutics Service"
  3. "Biomed Central Ltd"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (7)
  3. Guidelines (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  2. Department of Medicine (15)
  3. Melanoma and Immunotherapeutics Service (15)
  4. Solid Tumor Oncology Division (15)
  5. GSK Faculty (13)
  6. Biostatistics Service (7)

More Groups

People
  1. Jedd Wolchok (12)
  2. Paul Chapman (6)
  3. Taha Merghoub (6)
  4. Timothy Chan (6)
  5. Katherine Panageas (5)
  6. Michael Postow (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (3)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (14)
  2. Journal of Translational Medicine (1)
Publishers
  1. Biomed Central Ltd (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of immune-related cutaneous adverse events with dupilumab
    Journal Article

    Kuo, A. M. S.; Gu, S.; Stoll, J.; Moy, A. P.; Dusza, S. W.; Gordon, A.; Haliasos, E. C.; Janjigian, Y.; Kraehenbuehl, L.; Quigley, E. A.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
    Guidelines

    Galluzzi, L.; Vitale, I.; Warren, S.; Adjemian, S.; Agostinis, P.; Martinez, A. B.; Chan, T. A.; Coukos, G.; Demaria, S.; Deutsch, E.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Elf, S.; Ciboddo, M.; Zappasodi, R.; Pourpe, S.; Abdelfattah, N.; Chan, T.; Abdel-Wahab, O.; Mullally, A.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; Efficacy and safety of combined treatment
    Journal Article

    Anderson, E. S.; Postow, M. A.; Wolchok, J. D.; Young, R. J.; Ballangrud, A.; Chan, T. A.; Yamada, Y.; Beal, K.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Genome-scale neoantigen screening using ATLAS™ prioritizes candidates for immunotherapy in a non-small cell lung cancer patient
    Meeting Abstract

    Ghamsari, L.; Flano, E.; Jacques, J.; Liu, B.; Havel, J.; Makarov, V.; Merghoub, T.; Wolchok, J. D.; Hellmann, M. D.; Chan, T. A.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save